SCHEMBL7187840

SCHEMBL7187840

COc1ccc(CNc2nc(CCC(=O)O)nc3sc(C)c(C)c23)cc1Cl

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.45
ALDH1A1 P00352 3/20 0.45
LMNA P02545 2/20 0.45
HPGD P15428 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
NPSR1 Q6W5P4 2/20 0.45
STAT3 P40763 1/20 0.45
PDE5A O76074 2/20 0.42
BCDIN3D Q7Z5W3 2/20 0.42
GAA P10253 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6708187 0.95 KDM4E (0.44) KDM4EALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL6711591 0.94 KDM4E (0.43) KDM4EALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL6708284 0.93 KDM4E (0.49) KDM4EALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL27675471 0.91 KDM4E (0.43) KDM4EALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL6708130 0.90 KDM4E (0.47) KDM4EALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL6706629 0.89 KDM4E (0.47) KDM4EALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL6708275 0.88 KDM4E (0.46) KDM4EALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL6212918 0.85 ACHE (0.45) PDE5A
SCHEMBL6706625 0.85 ACHE (0.44) PDE5ABCDIN3D
SCHEMBL5251577 0.84 MAPT (0.46) SMN1; SMN2NPSR1PDE5AGAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1357915-A2 PHARMACEUTICAL FORMULATION COMPRISING PYRAZOLO 4,3-d]PYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS OR THIENOPYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS MERCK PATENT GmbH (DE) 2003-11-05 EP disclosed
WO-2002062343-A2 PHARMACEUTICAL FORMULATION COMPRISING PYRAZOLO[4,3-d]PYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS OR THIENOPYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS MERCK PATENT GMBH (DE) 2002-08-15 WO disclosed